Erlotinib Teva B.V.

Erlotinib Teva B.V. is an oral medication used for targeted therapy in certain types of cancer. This pharmaceutical is designed to inhibit specific proteins that contribute to cancer cell growth.

Erlotinib Teva B.V. is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by targeting and blocking the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' and the answer lies in its role as a targeted therapy for these specific cancer types.

Common effects of Erlotinib Teva B.V. may include skin rash, diarrhea, and fatigue. Some patients also report appetite loss and nausea. These effects can vary in severity and may not affect everyone who takes the medication.

Erlotinib Teva B.V. should be handled with care, especially by pregnant women or those planning to become pregnant, as it may cause harm to an unborn child. It is important to follow the advice of a healthcare professional regarding the safe use and storage of this medication.

Erlotinib Teva B.V. may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, smoking can reduce the effectiveness of Erlotinib.